ImmuCell Corporation — Balance Sheet Charts
8 snapshots of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Debt Structure
Working Capital Components
Total Assets↓-5.7% -$3M
$43M
Current Assets↑+12.6% +$2M
$17M
Cash & Equivalents↑+1.3% +$49K
$4M
ST Investments
—
Receivables↓-9.3% -$352K
$3M
Inventory↑+30.3% +$2M
$9M
Net PPE↓-16.9% -$4M
$21M
Goodwill↑+0.0% +$0
$96K
Intangibles↓-100.0% -$19K
$0
Total Liabilities↓-12.0% -$2M
$15M
Current Liabilities↓-9.8% -$434K
$4M
Account Payables
—
Long-Term Debt↑+0.6% +$58K
$9M
Short-Term Debt
$10M
Stockholders Equity↓-1.7% -$463K
$27M
Retained Earnings↓-7.3% -$1M
$-15M
Operating Lease ROU Asset↓-4.0% -$181K
$4M
Operating Lease Liability↓-0.8% -$34K
$4M
Finance Lease ROU Asset
—
Gross PP&E↓-14.0% -$6M
$40M
Accumulated Depreciation↓-10.5% -$2M
$19M
Inventory Raw Materials↑+21.7% +$295K
$2M
Inventory WIP↑+0.0% +$2K
$6M
Inventory Finished Goods↑+19498.1% +$2M
$2M
Debt Due Y1
$2M
Debt Due Y2
$1M
Debt Due Y3
$821K
Debt Due Y4
$783K
Debt Due Y5
$4M
Total Debt Carrying Amount↑+0.6% +$58K
$9M
Contract Asset
—